当前位置： SCI文献检索 > ANTICANCER RESEARCH期刊下所有文献 > Advances in Experimental Targeted Therapy and Immunotherapy for Patients with Glioblastoma Multiforme.

Advances in Experimental Targeted Therapy and Immunotherapy for Patients with Glioblastoma Multiforme.

Abstract：

:Glioblastoma multiforme (GBM) represents the most malignant primary brain tumor in adults with generally dismal prognosis, early clinical deterioration and high mortality. GBM is extremely invasive, characterized by intense and aberrant vascularization and high resistance to multimodal treatment. Standard therapy (surgery, radiotherapy and chemotherapy with temozolomide) has very limited effectiveness, with median overall survival of patients no longer than 15 months. Progress in genetics and epigenetics of GBM over the past decade has revealed various aberrations in cellular signaling pathways, the tumor microenvironment, and pathological angiogenesis. A number of targeted anticancer drugs, such as small-molecule kinase inhibitors and monoclonal antibodies, have been evaluated in clinical trials with newly-diagnosed, as well as recurrent GBM. Unfortunately, to date, only a single anti-angiogenic agent, bevacizumab, has been approved for the treatment of recurrent GBM in the USA and Canada. The novel possibilities of cancer immunotherapy, especially immune checkpoint inhibitors, are being evaluated in clinical trials of patients with GBM. The most recent clinical experiences with targeted therapy as well as immunotherapy of GBM are given in this review. The relative lack of success of some of these approaches recently revealed in well-designed randomized clinical trials is also discussed.

journal_name

Anticancer Res

journal_title

Anticancer research

authors

Polivka J Jr,Polivka J,Holubec L,Kubikova T,Priban V,Hes O,Pivovarcikova K,Treskova I

doi

10.21873/anticanres.11285

subject

Has Abstract

pub_date

2017-01-01 00:00:00

pages

21-33

issue

1

eissn

0250-7005

issn

1791-7530

pii

37/1/21

journal_volume

37

pub_type

杂志文章,评审

相关文献

ANTICANCER RESEARCH文献大全
  • Elective Nodal Irradiation for Non-small Cell Lung Cancer Complicated With Chronic Obstructive Pulmonary Disease Affects Immunotherapy Αfter Definitive Chemoradiotherapy.

    abstract：BACKGROUND/AIM:The aim of this retrospective study was to detect the frequency, reasons, and significant factors for not receiving immunotherapy after chemoradiotherapy in non-small cell lung cancer (NSCLC) patients. PATIENTS AND METHODS:Thirty-four patients with NSCLC received definitive chemoradiotherapy. The endpoi...

    journal_title：Anticancer research

    pub_type： 杂志文章

    doi：10.21873/anticanres.14720

    authors： Morimoto M,Nishino K,Wada K,Imamura F,Konishi K,Kuhara H,Tamiya M,Inoue T,Kunimasa K,Kimura M,Hirata T,Kanayama N,Toratani M,Kawachi H,Ohira K,Nakanishi E,Ohira S,Sagawa T,Miyazaki M,Matsunaga T,Kumagai T,Teshim

    更新日期：2020-12-01 00:00:00

  • Tumour markers CEA, NSE, SCC, TPA and CYFRA 21.1 in resectable non-small cell lung cancer.

    abstract：BACKGROUND:In the last few years, several prognostic factors have been investigated in order to identify among patients with completely resected non-small cell lung cancer (NSCLC) subsets at high risk of recurrence. In this context, the actual role of serum tumour markers is still unclear. The aim of this study was to ...

    journal_title：Anticancer research

    pub_type： 杂志文章

    doi：

    authors： Foa P,Fornier M,Miceli R,Seregni E,Santambrogio L,Nosotti M,Cataldo I,Sala M,Caldiera S,Bombardieri E

    更新日期：1999-07-01 00:00:00

  • Neoadjuvant chemotherapy in Barrett's carcinoma - prognosis and response prediction.

    abstract：:In spite of endoscopic surveillance programs, 90% of patients initially presenting with Barrett's carcinoma have locally advanced disease. In these patients, preoperative chemotherapy increases the chance of a curative resection in responding patients. Unfortunately, response occurs in only 50% of patients after chemo...

    journal_title：Anticancer research

    pub_type： 杂志文章,评审

    doi：

    authors： Schauer M,Knoefel WT

    更新日期：2010-04-01 00:00:00

  • Estrogen receptors alpha and beta immunohistochemical expression: clinicopathological correlations in pituitary adenomas.

    abstract：AIM:We investigated the immunohistochemical expression of estrogen receptors alpha (ERalpha) and beta (ERbeta) in pituitary adenoma subtypes combined with clinicopathological factors. MATERIALS AND METHODS:Pituitary adenomas (n=75) were immunostained for ERalpha and ERbeta using the streptavidin-biotin-peroxidase comp...

    journal_title：Anticancer research

    pub_type： 杂志文章

    doi：

    authors： Manoranjan B,Salehi F,Scheithauer BW,Rotondo F,Kovacs K,Cusimano MD

    更新日期：2010-07-01 00:00:00

  • Prognostic role of angiogenesis in colorectal cancer.

    abstract：:The need for dependable prognostic markers in colorectal cancer, both in the advanced as well the as adjuvant setting, is greater than ever. The introduction of new chemotherapeutic agents in the clinic, with different mechanisms of action as well as different side-effect profiles, has made this even more important. A...

    journal_title：Anticancer research

    pub_type： 杂志文章,评审

    doi：

    authors： Papamichael D

    更新日期：2001-11-01 00:00:00

  • Expression of nitrotyrosine is associated with angiogenesis in esophageal squamous cell carcinoma.

    abstract：BACKGROUND:In our previous study, it was suggested that nitrotyrosine, a product of nitrogen species, found in esophageal squamous cell carcinoma (ESCC), may contribute to the progression of esophageal cancer. MATERIALS AND METHODS:To clarify whether nitrotyrosine expression is associated with apoptosis and/or angioge...

    journal_title：Anticancer research

    pub_type： 杂志文章

    doi：

    authors： Kato H,Miyazaki T,Yoshikawa M,Nakajima M,Fukai Y,Masuda N,Ojima H,Tsukada K,Nishida Y,Kuwano H

    更新日期：2001-09-01 00:00:00

  • Different Gene Expression and Activity Pattern of Antioxidant Enzymes in Bladder Cancer.

    abstract：:The aim of this study was to evaluate the possible role in and contribution of antioxidant enzymes to bladder cancer (BC) etiology and recurrence after transurethral resection (TUR). We enrolled 40 patients with BC who underwent TUR and 100 sex- and age-matched healthy controls. The analysis was performed at diagnosis...

    journal_title：Anticancer research

    pub_type： 杂志文章

    doi：10.21873/anticanres.11387

    authors： Wieczorek E,Jablonowski Z,Tomasik B,Gromadzinska J,Jablonska E,Konecki T,Fendler W,Sosnowski M,Wasowicz W,Reszka E

    更新日期：2017-02-01 00:00:00

  • Evaluation of chemosensitivity testing with highly purified tumor cells in 435 patients with gastric carcinoma using an MTT assay.

    abstract：BACKGROUND:We evaluated the results of chemosensitivity testing for gastric cancer using a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay in terms of the correlation of chemosensitivity and clinicopathological findings. PATIENTS AND METHODS:We analyzed 435 consecutive patients with gastric c...

    journal_title：Anticancer research

    pub_type： 杂志文章

    doi：

    authors： Noguchi K,Iwahashi M,Tani M,Nakamura M,Nakamori M,Nakatani Y,Ueda K,Ishida K,Naka T,Ojima T,Hotta T,Mizobata S,Yamaue H

    更新日期：2005-03-01 00:00:00

  • Oxaliplatin in treatment of the cisplatin-resistant MKN45 cell line of gastric cancer.

    abstract：BACKGROUND AND AIM:The clinical efficiency of cisplatin (CDDP) against gastric cancer is often limited by the development of resistance. A third-generation platinum-containing agent, oxaliplatin (L-OHP), has been introduced for treating gastric cancer. Here, we studied oxaliplatin in vitro to reveal the mechanism of ac...

    journal_title：Anticancer research

    pub_type： 杂志文章

    doi：

    authors： Tozawa K,Oshima T,Kobayashi T,Yamamoto N,Hayashi C,Matsumoto T,Miwa H

    更新日期：2008-07-01 00:00:00

  • Unique molecular characteristics of the environmental responses of mucosal macrophages.

    abstract：:Macrophages are thought to be the cells that initially respond to environmental information and transmit this information to other immune cells. We hypothesize that there is a "network system" consisting of various tissue macrophages; the macrophages respond to stimulation and transmit secondary information to neighbo...

    journal_title：Anticancer research

    pub_type： 杂志文章,评审

    doi：

    authors： Nakata K,Inagawa H,Nishizawa T,Kohchi C,Taniguchi Y,Yoshioka N,Soma G

    更新日期：2006-11-01 00:00:00

  • Oxazolinodoxorubicin - a promising new anthracycline.

    abstract：:Oxazolinodoxorubicin, a doxorubicin analog with a modified daunosamine moiety was synthesized. The properties of this compound and the parent doxorubicin were compared. The cytotoxicity in vitro studies against several human tumor cell lines (PC-3, MCF-7, SW707, HL-60, RPMI 8226, ACHN) showed higher antiproliferative ...

    journal_title：Anticancer research

    pub_type： 杂志文章

    doi：

    authors： Lukawska M,Klopotowska D,Milczarek M,Wietrzyk J,Studzian K,Szmigiero L,Porebska A,Oszczapowicz I

    更新日期：2012-07-01 00:00:00

  • Clinical Significance of Serum p53 Antibody in the Early Detection and Poor Prognosis of Gastric Cancer.

    abstract：BACKGROUND:The aim of this retrospective study was to evaluate the clinical relevance of serum p53 antibody (S-p53Ab) as a biomarker and to investigate whether its diagnostic value could be improved when combined with other biomarkers of gastric cancer (GC). PATIENTS AND METHODS:Serum samples were obtained preoperativ...

    journal_title：Anticancer research

    pub_type： 杂志文章

    doi：10.21873/anticanres.11540

    authors： Kunizaki M,Fukuda A,Wakata K,Tominaga T,Nonaka T,Miyazaki T,Matsumoto K,Sumida Y,Hidaka S,Yasutake T,Sawai T,Hamamoto R,Nanashima A,Nagayasu T

    更新日期：2017-04-01 00:00:00

  • Growth regulation of multidrug resistant ovarian cancer cells by 1D7 monoclonal antibody.

    abstract：:The small molecular weight protein (p7) was overexpressed in the human ovarian carcinoma cell lines, SKVLB600 (selected for vinblastine resistance from SKOV3 cells). OVCAR 4/ADR100 (selected for doxorubicin resistance from NIH:OVCAR4) and (OVCAR4/VBL200 (selected for vinblastine resistance from NIH:OVCAR4). Trace amou...

    journal_title：Anticancer research

    pub_type： 杂志文章

    doi：

    authors： Yang X,Pagé M

    更新日期：1996-01-01 00:00:00

  • Electrochemotherapy with cisplatin in the treatment of tumor cells resistant to cisplatin.

    abstract：:The aim of our study was to investigate the role of electroporation in the treatment of cisplatin resistant tumor cells in vitro. For this purpose we used well characterized human ovarian carcinoma IGROV I cells and their resistant subclone IGROV 1/DDP. The cells were either continuously exposed to cisplatin or treate...

    journal_title：Anticancer research

    pub_type： 杂志文章

    doi：

    authors： Cemazar M,Sersa G,Miklavcic D

    更新日期：1998-11-01 00:00:00

  • Targeting aurora kinase A inhibits hypoxia-mediated neuroblastoma cell tumorigenesis.

    abstract：BACKGROUND/AIM:It is unknown whether hypoxia regulates aurora kinase A (AURKA), a serine/threonine kinase, in neuroblastoma to stimulate cell growth or migration. We sought to determine whether AURKA mediates hypoxia-induced regulation of neuroblastoma tumorigenicity. MATERIALS AND METHODS:Human neuroblastoma BE(2)-C ...

    journal_title：Anticancer research

    pub_type： 杂志文章

    doi：

    authors： Romain CV,Paul P,Lee S,Qiao J,Chung DH

    更新日期：2014-05-01 00:00:00

  • Probing the Molecular Mechanisms Governing the Oncolytic Activity of Paeonia suffruticosa on Triple-negative Breast Cancer Cells In Vitro.

    abstract：BACKGROUND/AIM:Extracts of Paeonia suffruticosa are traditionally used in Chinese medicine to increase blood flow. Recently, this extract has been shown to possess anti-tumor and anti-inflammatory properties, though this mechanism remains unknown. In the current work, we prepared extracts of P. suffruticosa and analyze...

    journal_title：Anticancer research

    pub_type： 杂志文章

    doi：10.21873/anticanres.11888

    authors： Kim D,Radin D,Leonardi D

    更新日期：2017-09-01 00:00:00

  • Pemetrexed Versus Erlotinib in the Second-line Treatment of Patients with Advanced-stage Non-squamous NSCLC Harboring Wild-type EGFR Gene.

    abstract：BACKGROUND:Pemetrexed and erlotinib represent different agents commonly used for the second-line treatment of patients with advanced-stage non-small cell lung cancer (NSCLC). PATIENTS AND METHODS:We analyzed data of 137 patients with advanced-stage non-squamous NSCLC treated with pemetrexed or erlotinib in the second ...

    journal_title：Anticancer research

    pub_type： 杂志文章

    doi：

    authors： Fiala O,Pesek M,Finek J,Svaton M,Minarik M,Benesova L,Bortlicek Z,Kucera R,Topolcan O

    更新日期：2016-01-01 00:00:00

  • Partial Body UV Exposure in Chronic Kidney Disease and Extrarenal Vitamin D Metabolism.

    abstract：BACKGROUND/AIM:Exposure of the skin to sunshine is the major natural source of vitamin D. In order to imitate this natural production of vitamin D for patients with chronic kidney disease, hemodialysis patients were exposed three times a week to radiation of the front part of both legs to normalize the vitamin D status...

    journal_title：Anticancer research

    pub_type： 杂志文章

    doi：10.21873/anticanres.12342

    authors： Krause R,Stange R,Roth HJ,Kaase H,Michalsen A,Holick MF

    更新日期：2018-02-01 00:00:00

  • A newly developed hexamethylmelamine derivative, SAE9 with both antitumor and aromatase-inhibitory activity.

    abstract：:Hexamethylmelamine (HMM) has previously been shown to be active against ovarian, breast and small cell lung cancer. However HMM dose not have aromatase-inhibitory activity. A newly developed HMM derivative, 2-N,N-dimethylamino-4, 6-bis (1-H-imidazol-1-yl)-1,3,5-triazine (SAE9), was found to have direct antitumor activ...

    journal_title：Anticancer research

    pub_type： 杂志文章

    doi：

    authors： Tanino H,Kubota T,Yamada Y,Koh JI,Takeuchi T,Kase S,Furukawa T,Takahashi M,Fukuda S,Ogose N

    更新日期：1993-05-01 00:00:00

  • Vimentin Regulates Invasiveness and Is a Poor Prognostic Marker in Non-small Cell Lung Cancer.

    abstract：BACKGROUND:Lung cancer cells often express vimentin. However, the function of vimentin in lung cancer cells has not been fully evaluated. MATERIALS AND METHODS:We evaluated the association between vimentin expression in resected non-small cell lung cancer (NSCLC) specimens and prognosis. Short-interfering RNA targetin...

    journal_title：Anticancer research

    pub_type： 杂志文章

    doi：

    authors： Tadokoro A,Kanaji N,Liu D,Yokomise H,Haba R,Ishii T,Takagi T,Watanabe N,Kita N,Kadowaki N,Bandoh S

    更新日期：2016-04-01 00:00:00

  • Androgen receptor-mTOR crosstalk is regulated by testosterone availability: implication for prostate cancer cell survival.

    abstract：BACKGROUND:Signaling between androgen receptor (AR) and mTOR may be crucial for prostate cancer cells to endure the low androgen and suboptimal nutrient conditions produced by androgen deprivation therapy. MATERIALS AND METHODS:AR and mTOR cross-talk was examined in LNCaP cells exposed to either high or low testostero...

    journal_title：Anticancer research

    pub_type： 杂志文章

    doi：

    authors： Wu Y,Chhipa RR,Cheng J,Zhang H,Mohler JL,Ip C

    更新日期：2010-10-01 00:00:00

  • Female Gender Is an Age-dependent Negative Prognostic Factor for Patients with Upper Tract Urothelial Carcinoma.

    abstract：AIM:To analyze female gender as a possible age-dependent prognostic factor for overall (OS) and cancer-specific survival (CSS) in patients with upper urinary tract urothelial carcinoma (UUTUC) after radical nephroureterectomy (RNU). PATIENTS AND METHODS:A total of 167 men and 101 women with UUTUC treated with RNU with...

    journal_title：Anticancer research

    pub_type： 杂志文章

    doi：

    authors： Sikic D,Wach S,Taubert H,Richterstetter M,Kunath F,Goebell PJ,Schick S,Olbert P,Huber J,Wullich B,Keck B

    更新日期：2015-07-01 00:00:00

  • Intensified M-VEC chemotherapy with G-CSF support as outpatient treatment for advanced bladder cancer.

    abstract：:The M-VAC regimen (methotrexate, vinblastine, doxorubicin and cisplatin) is widely used in the treatment of advanced or metastatic bladder cancer. In the present trial, an alternate week regimen of M-VEC (with epidoxorubicin instead of doxorubicin) supported by G-CSF (filgrastim) was evaluated. Eligible patients had m...

    journal_title：Anticancer research

    pub_type： 临床试验,杂志文章

    doi：

    authors： Pronzato P,Bertelli G,Bruna F,Tani F,Vaira F,Vanoli M,Vigani A

    更新日期：1997-05-01 00:00:00

  • Utility of the Free Vascularized Fibula Flap to Reconstruct Oncologic Defects in the Upper Extremity.

    abstract：BACKGROUND/AIM:Non-vascularized methods to reconstruct bone defects following tumor resection are associated with complications. As a result, the free vascularized fibular flap (FVF) has become a mainstay for reconstruction. The purpose of this study was to analyze FVF reconstruction in the upper extremity. PATIENTS A...

    journal_title：Anticancer research

    pub_type： 杂志文章

    doi：10.21873/anticanres.14246

    authors： Claxton MR,Shirley MB,Bakri K,Rose PS,Moran SL,Houdek MT

    更新日期：2020-05-01 00:00:00

  • Differential stimulatory and inhibitory responses of human MCF-7 breast cancer cells to linoleic acid and conjugated linoleic acid in culture.

    abstract：:Consumption of dietary fat has been linked to the high incidence of certain cancers. However, recent research has stimulated interest in conjugated linoleic acid (CLA), a newly recognized anticarcinogenic fatty acid. Human MCF-7 breast cancer cells were incubated for 12 d in culture medium supplemented with various co...

    journal_title：Anticancer research

    pub_type： 杂志文章

    doi：

    authors： Shultz TD,Chew BP,Seaman WR

    更新日期：1992-11-01 00:00:00

  • Modification of the blood-brain barrier permeability following intracarotid infusion of vinorelbine.

    abstract：:The effects of the antineoplastic compound, vinorelbine, on the permeability of the blood-brain barrier (BBB) to the complex Evans blue/albumin were studied. Vinorelbine, at a dose range from 5 to 10 mg/kg, was infused (4 ml/kg over 2 min) into the left carotid artery of anesthetised male Sprague-Dawley rats. BBB disr...

    journal_title：Anticancer research

    pub_type： 杂志文章

    doi：

    authors： Mouchard-Delmas C,Gourdier B,Vistelle R,Wiczewski M

    更新日期：1995-11-01 00:00:00

  • Multicyclic dose-intensive chemotherapy supported by autologous blood progenitor cell transplantation for relapsed small cell lung cancer.

    abstract：:We report two cases with small cell lung cancer (SCLC) receiving multicyclic dose-intensified chemotherapy (DI-CT) supported by autologous blood progenitor cell transplantation (ABPCT). Both cases were initially treated with cisplatin (CDDP), etoposide (ETP) and concurrent thoracic irradiation, however they had recurr...

    journal_title：Anticancer research

    pub_type： 杂志文章

    doi：

    authors： Fujimoto N,Ueoka H,Kiura K,Tabata M,Bessho A,Takata I,Sunami K,Hiramatsu Y,Ikeda K,Tanimoto M,Harada M

    更新日期：2003-09-01 00:00:00

  • Anticancer effects of licofelone (ML-3000) in prostate cancer cells.

    abstract：BACKGROUND:Licofelone, a potent antiinflammatory agent has been reported to interfere with the cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) signaling pathways with few side-effects. However, the underlying mechanism of licofelone against human cancer is not understood. MATERIALS AND METHODS:Human and mouse pros...

    journal_title：Anticancer research

    pub_type： 杂志文章

    doi：

    authors： Narayanan NK,Nargi D,Attur M,Abramson SB,Narayanan BA

    更新日期：2007-07-01 00:00:00

  • First-line Bevacizumab and Paclitaxel for HER2-negative Metastatic Breast Cancer: A French Retrospective Observational Study.

    abstract：AIM:To assess outcomes in patients treated with first-line bevacizumab-containing therapy for human epidermal growth factor receptor (HER)2-negative metastatic breast cancer (mBC) at a single centre with a homogenous standard-of-care. PATIENTS AND METHODS:Information on patient and disease characteristics, efficacy, a...

    journal_title：Anticancer research

    pub_type： 杂志文章

    doi：10.21873/anticanres.11462

    authors： Dieras V,Pop S,Berger F,Dujaric ME,Beuzeboc P,Escalup L,Bidard FC,Cottu PH,LE Tourneau C,Piperno-Neumann S,Laurence V,Robain M,Asselain B,Pierga JY

    更新日期：2017-03-01 00:00:00

  • Influence of acetic acid on a pap smear of dysplastic lesion.

    abstract：BACKGROUND:Cervical cancer prevention is performed by taking Pap smears. The correct execution of the smear is crucial as an inadequate smear might result in underdiagnosis. The second means of cervical cancer prevention is visual inspection of the cervix uteri with acetic acid, while often both methods are combined. W...

    journal_title：Anticancer research

    pub_type： 杂志文章

    doi：

    authors： Hoellen F,Bohlmann MK,Brade J,Rody A,Diedrich K,Husstedt WD,Hornemann A

    更新日期：2013-03-01 00:00:00